If you invest in the stock market, you must know the Johnson Pharmacare share price targets for 2026, 2027, 2028, 2029, 2030, 2040, and 2050. Here, you will get detailed information regarding all your queries, such as its fundamentals, shareholdings, financial performance, future predictions, and more.
About Johnson Pharmacare Ltd
Johnson Pharmacare is an emerging Indian pharmaceutical company focused on manufacturing affordable medicines and healthcare products. The company specializes in generic drugs, tablets, and healthcare solutions that meet everyday medical needs. Its goal is to provide safe, high-quality, and affordable medicines to people across the country. Johnson Pharmacare is attracting the attention of investors looking for pharma stocks, healthcare investments, and long-term growth opportunities in the Indian pharmaceutical sector. Given the growing demand for healthcare and medicines, the company has strong potential in the rapidly growing pharmaceutical market.
Fundamental Analysis of Johnson Pharmacare
- Market Cap: ₹33.0 Cr.
- High / Low: ₹0.97 / ₹0.47
- Stock P/E: —
- Book Value: ₹1.02
- Dividend Yield: 0.00%
- ROCE: -0.43%
- ROE: -0.44%
- Face Value: ₹1
Johnson Pharmacare Share Price Target 2026
After analysing past price trends and market performance, it is estimated that the Johnson Pharmacare stock price could reach a minimum of ₹0.3 and potentially achieve a maximum target of ₹0.7 in the year 2026.
Johnson Pharmacare Share Price Target 2027
After analysing past price trends and market performance, it is estimated that the Johnson Pharmacare stock price could reach a minimum of ₹0.4 and potentially achieve a maximum target of ₹0.8 in the year 2027.
Johnson Pharmacare Share Price Target 2028
After analysing past price trends and market performance, it is estimated that the Johnson Pharmacare stock price could reach a minimum of ₹0.6 and potentially achieve a maximum target of ₹1 in the year 2028.
Johnson Pharmacare Share Price Target 2029
After analysing past price trends and market performance, it is estimated that the Johnson Pharmacare stock price could reach a minimum of ₹1 and potentially achieve a maximum target of ₹5 in the year 2029.
Johnson Pharmacare Share Price Target 2030
After analysing past price trends and market performance, it is estimated that the Johnson Pharmacare stock price could reach a minimum of ₹5 and potentially achieve a maximum target of ₹10 in the year 2030.
Johnson Pharmacare Share Price Target 2040
After analysing past price trends and market performance, it is estimated that the Johnson Pharmacare stock price could reach a minimum of ₹20 and potentially achieve a maximum target of ₹40 in the year 2040.
Johnson Pharmacare Share Price Target 2050
After analysing past price trends and market performance, it is estimated that the Johnson Pharmacare stock price could reach a minimum of ₹80 and potentially achieve a maximum target of ₹100 in the year 2050.
Shareholding Pattern of Johnson Pharmacare
- Retail and Others: 100%
Retail & Others: 100%Should You Invest in Johnson Pharmacare Stock?
| Year | Target Price (₹) |
|---|---|
| 2026 | 0.3–0.7 |
| 2027 | 0.4–0.8 |
| 2028 | 0.6–1 |
| 2029 | 1–5 |
| 2030 | 5–10 |
| 2040 | 20–40 |
| 2050 | 80–100 |
Whether you should invest or not, it depends on the many factors. Let us know the risk and opportunities to invest in Johnson Pharmacare stock.
Opportunities
- The growing demand for affordable medicines in India offers strong revenue growth potential and numerous investment opportunities in pharmaceutical stocks.
- The focus on generic drugs improves profit margins and attracts investors interested in companies providing low-cost healthcare solutions.
- The expansion of the healthcare sector and increasing medical needs create long-term growth opportunities for pharmaceutical stocks.
- The ability to launch new drugs and products can increase market share and boost investor confidence.
- Strong demand in the domestic market leads to stable earnings and business growth.
Risks
- Strict government regulations and delays in drug approvals may delay product launches and impact revenue growth.
- Strong competition from large pharmaceutical companies may reduce pricing power and reduce profit margins.
- Dependence on raw material supplies may impact production levels and overall business performance.
- Changes in pharmaceutical pricing policies could negatively impact earnings and stock market performance.
- The risk of product failure or regulatory issues could reduce investor confidence and growth prospects.
Key Competitors of Johnson Pharmacare
Key competitors or peer companies of Johnson Pharmacare are Sun Pharmaceutical Industries, Dr. Reddy’s Laboratories, Cipla, Lupin, Aurobindo Pharma, Zydus Lifesciences, Torrent Pharmaceuticals, Alkem Laboratories, Biocon, and Glenmark Pharmaceuticals.
We have more than 7 years of experience in the stock market and analysis, and we are dedicated to delivering accurate, real-time market updates and insightful analysis. With a sharp eye on the Indian and global stock markets, we simplify complex financial data and trends to help investors make informed decisions.
Disclaimer: All the information provided in this article is for educational purposes only. We are not a SEBI registered firm. DateUpdateGo always advises seeking guidance from a certified financial advisor before making any investment-related decisions.
